KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.900
-0.064 (-6.64%)
At close: Dec 5, 2025, 4:00 PM EST
0.888
-0.012 (-1.33%)
After-hours: Dec 5, 2025, 7:59 PM EST
KALA BIO Stock Forecast
KALA's stock price has decreased by -86.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for KALA BIO stock have an average target of 31.5, with a low estimate of 30 and a high estimate of 33. The average target predicts an increase of 3,400.00% from the current stock price of 0.90.
Analyst Consensus: Buy
* Price targets were last updated on Sep 11, 2025.
Analyst Ratings
The average analyst rating for KALA BIO stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $35 | Strong Buy | Maintains | $12 → $35 | +3,788.89% | Sep 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $15 → $33 | Buy | Maintains | $15 → $33 | +3,566.67% | Sep 11, 2025 |
| Mizuho | Mizuho | Buy Initiates $30 | Buy | Initiates | $30 | +3,233.33% | Sep 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $15 | Buy | Initiates | $15 | +1,566.67% | Jun 2, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.55
from -10.15
EPS Next Year
-0.90
from -5.55
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -4.67 | -0.55 | |
| Avg | -5.55 | -0.90 | |
| Low | -6.31 | -1.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.